Coast to Coast AM (May-19-2012) FDA, Big Pharma

Posted: Published on June 14th, 2012

This post was added by Dr. Richardson



13-06-2012 04:51 Date: 05-19-12 Host: John B. Wells Guests: Jonathan Emord, Douglas Dietrich Attorney Jonathan Emord discussed the corrupt relationship between the FDA and 'Big Pharma'. "Without question the FDA's system for drug approval is broken and results in horrific consequences both when it approves drugs and when it denies terminally-ill patients access to drugs," he stated. The FDA plays favorites with large pharmaceutical companies, Emord continued, citing the example of a Sanofi-Aventis drug called Ketek that was approved even after it had been revealed the primary clinical trials were entirely made up. Perhaps even worse than approving potentially unsafe drugs, the FDA often denies patients access to promising experimental treatments. A drug called Gleevec was found effective in treating Chronic Myelogenous Leukemia yet the FDA denied, and essentially condemned to death, thousands of patients, Emord said. Eighty percent of the few subjects allowed to receive the treatment are still alive, he added. Emord encouraged listeners who have been denied access to treatment by the FDA to email him their stories at jemord@emord.com. Emord commented on recent developments around the National Defense Authorization Act (NDAA) and similar draconian legislation. Section 1021 of the NDAA allows the armed forces to arrest any American citizen who is engaged in "substantially supporting" a terrorist organization, he explained. According to Emord, one significant problem is the vague wording of ...

Read the original here:
Coast to Coast AM (May-19-2012) FDA, Big Pharma

Related Posts
This entry was posted in FDA Stem Cell Trials. Bookmark the permalink.

Comments are closed.